EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report

Zhuo Wang, Chao Li, Lili Yue

Experimental and Therapeutic Medicine · 12.06.2026 · 32 (2) · 1-6

DOI: 10.3892/etm.2026.13209 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 12.06.2026. Verfasst von Zhuo Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Liaohua Hospital, Liaoyang, Liaoning 111003, P.R. China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

case reporthepatotoxicityimmune-related adverse eventstislelizumabtoxic epidermal necrolysis

Autor:innen und Institutionen

  • Department of Medical Oncology, Liaohua Hospital, Liaoyang, Liaoning 111003, P.R. China.
  • Department of Research, Liaohua Hospital, Liaoyang, Liaoning 111003, P.R. China.

Zitieren

APA

Wang, Z., Li, C., & Yue, L. (2026). Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report. Experimental and Therapeutic Medicine, 32(2), 1-6. https://doi.org/10.3892/etm.2026.13209

Vancouver

Wang Z, Li C, Yue L. Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report. Experimental and Therapeutic Medicine. 2026;32(2):1-6. doi:10.3892/etm.2026.13209

BibTeX
@article{Wang2026,
  author = {Wang, Zhuo and Li, Chao and Yue, Lili},
  title = {Sequential fulminant hepatitis and toxic epidermal necrolysis induced by tislelizumab: A case report},
  journal = {Experimental and Therapeutic Medicine},
  year = {2026},
  volume = {32},
  number = {2},
  pages = {1--6},
  doi = {10.3892/etm.2026.13209}
}
Kostenlos starten →